Obesity Featured Articles

  1. Reformulating An In-Clinic IV To At-Home Injection Puts Patients At The Center 4/20/2026

    For Soligenix, reformulation was not a detour but a necessary step toward optimizing a therapy for real-world use. Discover how the team reformulated its drug delivery from in-clinic to at-home administration.

  2. Reminder: FDA Approval Is Not Synonymous With Commercial Success 4/17/2026

    Life sciences expert Rena Roseberg, Ph.D., warns that research and commercial efforts cannot operate within a vacuum. Here, she shares best practices on developing a therapeutic product with solid understanding of its commercial viability. 

  3. What Sites, Sponsors, Vendors, And CROs Can All Agree On 4/17/2026

    Experts representing sponsors, sites, vendors, and CROS discussed at Life Sciences Future SW the pain points and the opportunities that lie ahead in clinical research.

  4. Bringing Intelligence Into The Flow Of Clinical Trials 4/16/2026

    AI-driven trial intelligence turns complex data into real-time insight, enabling earlier risk detection, stronger oversight, and smarter decisions across the trial lifecycle.

  5. AI Amplifies Capabilities But Also Risks: Learn The Legal Consequences Of AI In Clinical Research 4/16/2026

    Companies that successfully use AI are those that understand technology magnifies accountability. Anyone that fails to internalize that lesson could find themselves defending the very systems they relied on to bring those products to market.

  6. Is It Time To Replace RECIST — Or Just Add AI? 4/16/2026

    Immunocore Chief Regulatory and Quality Officer Mark Moyer explains why new tools, including AI-based approaches, may better capture cancer treatment response than existing measures, such as ir-RECIST.

  7. Managing Opportunities And Risks In Generative AI Use For Clinical Research 4/15/2026

    Explore how to bridge the gap between generative AI potential and clinical regulations through smarter oversight, adversarial agents, and a workforce prepared for human-AI collaboration.

  8. Build Systems That Scale With Every Stage Of Growth 4/15/2026

    Learn how to synchronize finance and R&D with a scalable operational framework. Automate manual steps and strengthen compliance to ensure your infrastructure evolves as fast as your science.

  9. Understanding When AI Models Need To Be Validated For Regulated Industries 4/15/2026

    Focus AI validation on decision impact rather than just algorithms. Aligning assurance with intended use and human oversight ensures safety while enabling faster, more compliant adoption.

  10. Improving Rare Disease Recruitment With Data And AI 4/15/2026

    Finding patients for rare disease clinical trials can be an uphill battle; fortunately, there are ways sponsors can address the most common stumbling blocks in the recruitment process.